Zydus Pharmaceuticals (USA) Inc. is recalling approximately 37,992 cartons of Lansoprazole Delayed-Release Orally Disintegrating Tablets (15 mg and 30 mg) because the medication failed to meet dissolution specifications during testing. This prescription drug, used to treat stomach acid conditions, may not break down properly in the body, which can prevent the patient from receiving the full intended dose of the medication. Consumers who have these tablets should contact their healthcare provider or pharmacist for guidance on continuing their treatment.
The tablets failed to dissolve at the required rate, which means the medication may not be absorbed correctly by the body. This could lead to a decrease in the drug's effectiveness, potentially resulting in inadequately managed acid-related gastrointestinal symptoms.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.